Zhenwei Wang
Shanghai University
5 Papers
1 Citations
Zhenwei Wang is an academic researcher from Shanghai University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
TL;DR: Results obtained in the current study may provide clues for treatment of 2019-nCoV pneumonia and the efficacy of antiviral treatment including lopinavir/ritonavir, arbidol, and SFJDC warrants further verification in future study.
586
A mixed-reality stimulator for lumbar puncture training: a pilot study
TL;DR: In this article , a mixed-reality stimulator was used for lumbar puncture training with 40 participants, including medical students, residents and faulty with varied levels of experience.
7
Evaluating the Effects of Heat-Clearing Traditional Chinese Medicine in Stable Bronchiectasis by a Series of N-of-1 Trials
TL;DR: The experimental design of this study can make the TCM individualized treatment fully play its role and can detect the individualized tendencies according to the severity of phlegm and heat in some subjects.
Effects of pulmonary-based Qigong exercise in stable patients with chronic obstructive pulmonary disease: a randomized controlled trial
Linhong Jiang,Jiacheng Shi,Yidie Bao,Zhenwei Wang,Wei-chan Wu,Xiaodan Liu +5 more
TL;DR: The findings of study suggest that the proposed program of 3 months of PQE intervention has significant improvement in exercise capacity, skeletal muscle strength, and quality of life of COPD-stable patients.
Effects of external diaphragm pacing combined with conventional rehabilitation therapies in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
Linhong Jiang,Pingping Sun,Peijun Li,Wei-chan Wu,Zhenwei Wang,Xiaodan Liu +5 more
TL;DR: EDP-CRTs have better effects on pulmonary function, PaCO2, dyspnea, exercise capacity, and quality of life in COPD patients than CRTs, and the duration to achieve the most effective treatment is 2–4 weeks.